Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

George David Lowe


  • Ceo And President at Aeglea Biotherapeutics Inc. (AGLE), 2017-03-22
  • Director at Arca Biopharma Inc. (ABIO), 2009-07-22
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ABIO $3.94 78,800 Director 129,600 2009-07-21 Filing
ABIO $4.44 102,000 Director 208,400 2009-07-20 Filing
ABIO $4.19 25,000 Director 310,400 2009-07-17 Filing
ABIO $3.90 6,100 Director 335,400 2009-06-15 Filing
ABIO $3.94 3,800 Director 341,500 2009-06-12 Filing